Author: RCG Admin

Technical Advance: New in vitro method for assaying the migration of primary B cells using an endothelial monolayer as substrate.

Stewart-Hutchinson P.J., Szasz T.P., Jaeger E.R., Onken M.D., Cooper J.A., and Morley S.C.
Technical Advance: New in vitro method for assaying the migration of primary B cells using an endothelial monolayer as substrate.
J Leukoc Biol. 102(3):941-948. doi: 10.1189/jlb.1TA0117-008R. (2017) (Abstract)

Jim Janetka’s work featured in The Source

Congratulations to Jim Janetka, whose work on UTI treatments was featured in The Source.

Dr. Janetka helped with a new study that may prevent the common problem of recurrent urinary tract infections with the use of a molecular decoy that targets e. coli bacteria.

You can read more about the work in the The Source by clicking HERE or on the picture of e. coli.

Selective depletion of uropathogenic E. coli from the gut by a FimH antagonist

Caitlin N. Spaulding, Roger D. Klein, Ségolène Ruer, Andrew L. Kau, Henry L. Schreiber, Zachary T. Cusumano, Karen W. Dodson, Jerome S. Pinkner, Daved H. Fremont, James W. Janetka, Han Remaut, Jeffrey I. Gordon, & Scott J. Hultgren
Selective depletion of uropathogenic E. coli from the gut by a FimH antagonist
Nature (2017) (Abstract)

Pedal the Cause – Happy Hour Fundraiser

Please join us for a Happy Hour at itap in the Central West End to raise money for cancer research! Sixty percent of sales of the designated beer will be donated (beer TBA). Feel free to stay around after Happy Hour for itap’s weekly trivia night too!

The event will be on Thursday, June 15th, from 4 PM to 7 PM.

More information and links can be found on HERE.

Targeting the tumor-promoting microenvironment in MET-amplified NSCLC cells with a novel inhibitor of pro-HGF activation

Benjamin Y. Owusu, Shantasia Thomas, Phanindra Venukadasula, Zhenfu Han, James W. Janetka, Robert A. Galemmo Jr and Lidija Klampfer
Targeting the tumor-promoting microenvironment in MET-amplified NSCLC cells with a novel inhibitor of pro-HGF activation
Oncotarget. 8(38):63014-63025. doi: 10.18632/oncotarget.18260. (2017) (Abstract)

Small Molecule Bacterial Lectin Antagonists for UTI Treatment and Prevention

January 30th, 2017 – Jim Janetka, PhD, Associate Professor of Biochemistry and Molecular Biophysics and Chemistry Adjunct, along with Scott Hultgren, PhD, Helen L. Stoever Professor of Molecular Microbiology received and a four year grant award from the National Institute of Diabetes and Digestive and Kidney Diseases for his research entitled “Small Molecule Bacterial Lectin Antagonists for UTI Treatment and Prevention”.